Investing Profile

Yizhen Dong(1)

InvestorVC
Life Sciences & Healthcare Partner, VC & Growth Equity at Global Founders Capital
kochdisruptivetechnologies.co...San Francisco, California
Photo of Yizhen Dong, Partner at Global Founders Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Connected to 1 investor on Signal.

Sign in with Google →
Stanford University Network
1141 CONNECTIONS
The University of Chicago Booth School of Business Network
187 CONNECTIONS
Vanderbilt University Network
102 CONNECTIONS
Vanderbilt University Network
102 CONNECTIONS
University of Maryland Network
81 CONNECTIONS
cb
Global Founders Capital Partner
$100K - $5.0M
$1.5M
1
$1B
CompanyStageDateRound SizeTotal Raised
Valo Health
Series BJan 2021$190M
$300M
Co-investors: Soheil Mirpour (Global Founders Capital), chase koch
Breakthrough technologies in data-driven healthcare and computational biology across research tools, diagnostics, therapeutics, and synthetic biology.
Investment Banking martinwolf | M&A AdvisorsPresent
Management Consultant ZSPresent
Strategic Planning GenentechPresent
Clin Dev & Product Launch GenentechPresent
Board Observer Hinge HealthPresent
Principal, Life Sciences and Healthcare VC 11.2 CapitalPresent
Board Director Oshi HealthPresent
Board Observer ArteraAIPresent
Board Observer CellaresPresent
Healthcare & Life Sciences Growth Equity Koch Disruptive TechnologiesPresent
Investor The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory UniversityPresent
Life Sciences & Healthcare Partner, VC & Growth Equity Global Founders CapitalPresent
Co-Founder The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory UniversityPresent
Co-Founder and CXO The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory UniversityPresent
Co-Founder & Interim CEO The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory UniversityPresent
Co-Founder & CEO The Wallace H. Coulter Department of Biomedical Engineering at Georgia Tech and Emory UniversityPresent
Summer Associate Data CollectivePresent
Venture Associate Hyde Park AngelsPresent
Venture Consultant Presidio PartnersPresent
Partner Global Founders Capital2020 - 2022
Principal 11.2 Capital2016 - 2020
Strategic Planning Roche / Genentech2013 - 2014
Associate Consultant ZS Associates2011 - 2014
University of Maryland Master's degree Biotechnology
University of Maryland Master's degree Computational Biology
Vanderbilt University BA; Full tuition scholar senator scholar
The University of Chicago Booth School of Business Master of Business Administration (MBA) Finance, Entrepreneurship, General Management
Stanford University Genetics and Genomics
Vanderbilt University
Sign in with Google →
Sign in with Google →